Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Zhirang Zhang"'
Autor:
Zhongda Lin, Fanqiang Meng, Yumeng Ma, Chi Zhang, Zhirang Zhang, Zhaoxin Yang, Yuan Li, Linlin Hou, Yuzhong Xu, Xin Liang, Xudong Zhang
Publikováno v:
Bioactive Materials, Vol 32, Iss , Pp 12-27 (2024)
Immune checkpoint blockade (ICB) therapy potently revives T cell's response to cancer. However, patients suffered with tumors that had inadequate infiltrated immune cells only receive limited therapeutic benefits from ICB therapy. Synthetic biology p
Externí odkaz:
https://doaj.org/article/dde4f1c77556432a96cdf94b1cf9abd4
Autor:
Wenli Fang, Liyan Li, Zhongda Lin, Yuli Zhang, Zhangyan Jing, Yuan Li, Zhirang Zhang, Linlin Hou, Xin Liang, Xingding Zhang, Xudong Zhang
Publikováno v:
Extracellular Vesicle, Vol 2, Iss , Pp 100021- (2023)
Interleukin 15 (IL-15) is a pivotal immune cytokine that responses to cancer stress signals and maintains tissue-resident memory T (TRM) cells. It is therefore considered as a potent therapeutic immunomodulator agonist cancer. However, in addition to
Externí odkaz:
https://doaj.org/article/a7346331fdc34843ba16d5b08590b4a2
Autor:
Fanqiang Meng, Liyan Li, Zhirang Zhang, Zhongda Lin, Jinxie Zhang, Xiao Song, Tianyuan Xue, Chenyang Xing, Xin Liang, Xudong Zhang
Publikováno v:
Journal of Extracellular Vesicles, Vol 11, Iss 12, Pp n/a-n/a (2022)
Abstract Neoantigens derived from mutant proteins in tumour cells could elicit potent personalized anti‐tumour immunity. Nevertheless, the layout of vaccine vehicle and synthesis of neoantigen are pivotal for stimulating robust response. The power
Externí odkaz:
https://doaj.org/article/200e758ebde245d38a381933cbcaca6b
Autor:
Na Xie, Hui Zhu, Yiqun Zhang, Zeng Huang, Zhixuan Fang, Zheng Liu, Dong Li, Shiwei Feng, Chunsheng Guo, Yamin Zhang, Bo Liu, Lixing Zhou, Xing Liu, Yerong Sun, Zhirang Zhang, Yilin Li, Zhiwen Yao
Publikováno v:
IEEE Transactions on Electron Devices. 70:544-549
Autor:
Tianyuan Xue, Zhirang Zhang, Tianliang Fang, Baoqi Li, Yuan Li, Liyan Li, Yanghua Jiang, Fangfang Duan, Fanqiang Meng, Xin Liang, Xudong Zhang
Publikováno v:
Nano Research. 15:5295-5304
Autor:
Xuemei Li1 lxm198022@126.com, Zhirang Zhang1 zrzhang46@126.com, Baojun Li1 baojunli@cuit.edu.cn
Publikováno v:
Southeast Asian Bulletin of Mathematics. 2018, Vol. 42 Issue 4, p607-612. 6p.
Autor:
Fanqiang Meng, Xingding Zhang, Yang Kang, Hongbo Chen, Zhirang Zhang, Xinyu Ye, Li-Yan Li, Qianwei Miao, Qian Chen, Tianliang Fang, Xin Liang, Baoqi Li, Tianyuan Xue, Xudong Zhang, Jinxie Zhang
Publikováno v:
Theranostics
Immune checkpoint blockade therapies, especially those targeting the programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) have achieved impressive clinical responses in multiple types of cancers. To optimize the therapeutic effect of the check
Autor:
Zhirang Zhang1 zrzhang46@126.com, Jitao Cen1 cenjitao@163.com
Publikováno v:
Southeast Asian Bulletin of Mathematics. 2017, Vol. 41 Issue 4, p615-626. 12p.
Autor:
Tianliang Fang, Baoqi Li, Meng Li, Yuli Zhang, Zhangyan Jing, Yuan Li, Tianyuan Xue, Zhirang Zhang, Wenli Fang, Zhongda Lin, Fanqiang Meng, Liyan Li, Yang Yang, Xingding Zhang, Xin Liang, Shu‐Na Chen, Jun Chen, Xudong Zhang
Publikováno v:
Small Methods. 7:2200925
Immune intervention of B cell activation to blockade the production of autoantibodies provokes intense interest in the field of systemic lupus erythematosus (SLE) therapy development. Although the survival rate for SLE is improved, many patients die
Autor:
Baoqi Li, Tianliang Fang, Yuan Li, Tianyuan Xue, Zhirang Zhang, Liyan Li, Fanqiang Meng, Jinqiang Wang, Linlin Hou, Xin Liang, Xudong Zhang, Zhen Gu
Publikováno v:
Nano Today. 46:101606